Exact Mass: 903.6469

Exact Mass Matches: 903.6469

Found 47 metabolites which its exact mass value is equals to given mass value 903.6469, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PE(24:0/PGF1alpha)

(2-aminoethoxy)[(2R)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoyl}oxy)-3-(tetracosanoyloxy)propoxy]phosphinic acid

C49H94NO11P (903.6564)


PE(24:0/PGF1alpha) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(24:0/PGF1alpha), in particular, consists of one chain of one tetracosanoyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(PGF1alpha/24:0)

(2-aminoethoxy)[(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]heptanoyl}oxy)-2-(tetracosanoyloxy)propoxy]phosphinic acid

C49H94NO11P (903.6564)


PE(PGF1alpha/24:0) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(PGF1alpha/24:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of tetracosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(24:0/PGF1alpha)

PE(24:0/PGF1alpha)

C49H94NO11P (903.6564)


   

PE(PGF1alpha/24:0)

PE(PGF1alpha/24:0)

C49H94NO11P (903.6564)


   

SHexCer 18:1;2O/25:1

SHexCer 18:1;2O/25:1

C49H93NO11S (903.6469)


   
   

SHexCer 29:1;2O/14:1

SHexCer 29:1;2O/14:1

C49H93NO11S (903.6469)


   

SHexCer 27:0;2O/16:2

SHexCer 27:0;2O/16:2

C49H93NO11S (903.6469)


   

SHexCer 17:1;2O/26:1

SHexCer 17:1;2O/26:1

C49H93NO11S (903.6469)


   

SHexCer 25:1;2O/18:1

SHexCer 25:1;2O/18:1

C49H93NO11S (903.6469)


   

SHexCer 20:1;2O/23:1

SHexCer 20:1;2O/23:1

C49H93NO11S (903.6469)


   

SHexCer 19:0;2O/24:2

SHexCer 19:0;2O/24:2

C49H93NO11S (903.6469)


   

SHexCer 17:0;2O/26:2

SHexCer 17:0;2O/26:2

C49H93NO11S (903.6469)


   

SHexCer 27:1;2O/16:1

SHexCer 27:1;2O/16:1

C49H93NO11S (903.6469)


   

SHexCer 15:0;2O/28:2

SHexCer 15:0;2O/28:2

C49H93NO11S (903.6469)


   

SHexCer 19:1;2O/24:1

SHexCer 19:1;2O/24:1

C49H93NO11S (903.6469)


   

SHexCer 30:1;2O/13:1

SHexCer 30:1;2O/13:1

C49H93NO11S (903.6469)


   

SHexCer 22:1;2O/21:1

SHexCer 22:1;2O/21:1

C49H93NO11S (903.6469)


   

SHexCer 24:1;2O/19:1

SHexCer 24:1;2O/19:1

C49H93NO11S (903.6469)


   

SHexCer 25:0;2O/18:2

SHexCer 25:0;2O/18:2

C49H93NO11S (903.6469)


   

SHexCer 23:1;2O/20:1

SHexCer 23:1;2O/20:1

C49H93NO11S (903.6469)


   

SHexCer 21:1;2O/22:1

SHexCer 21:1;2O/22:1

C49H93NO11S (903.6469)


   

SHexCer 23:0;2O/20:2

SHexCer 23:0;2O/20:2

C49H93NO11S (903.6469)


   

SHexCer 15:1;2O/28:1

SHexCer 15:1;2O/28:1

C49H93NO11S (903.6469)


   

SHexCer 28:1;2O/15:1

SHexCer 28:1;2O/15:1

C49H93NO11S (903.6469)


   

SHexCer 21:0;2O/22:2

SHexCer 21:0;2O/22:2

C49H93NO11S (903.6469)


   

SHexCer 16:1;2O/27:1

SHexCer 16:1;2O/27:1

C49H93NO11S (903.6469)


   

2-[[(4E,8E,12E)-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenoyl]amino]-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenoyl]amino]-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C55H88N2O6P+ (903.638)


   

2-[[(E)-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenoyl]amino]-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(E)-2-[[(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-6,9,12,15,18,21,24,27,30,33,36,39-dodecaenoyl]amino]-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C55H88N2O6P+ (903.638)